Download the article in PDF format *** This article explores the recent reclassification of aspartame, a widely used artificial sweetener, by the World Health Organization (WHO) as "Possibly Carcinogenic to Humans." The move has stirred varying responses from regulatory bodies, companies, and media outlets, highlighting the complexities that consumers face in discerning fact from opinion … Continue reading Aspartame Debate: Are Economic Interests Clouding the Truth?
Category: Bioethics and Pharmaceuticals
Bioethics, Healthcare, and Pharmaceuticals (e.g., corporations and bioethics; healthcare affordability, drug safety).
The Cost of Manipulation: The Irresponsible Abuse of Technological Opacity in the Pharmaceutical Industry
Download the article in PDF format *** This article explores the risks associated with the irresponsible use of technology in the pharmaceutical industry, including scientific manipulation in drug trials, scientific misrepresentation through ghost-written publications, and abuse of technology through the misrepresentation of risks. The article highlights the negative impacts of these practices on patients, healthcare … Continue reading The Cost of Manipulation: The Irresponsible Abuse of Technological Opacity in the Pharmaceutical Industry
Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
Download the article in PDF format *** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical companies Pfizer Inc. and Flynn Pharma Limited £63 million and £6 million respectively. The fines levied against these companies are the result of them abusing their market position as a means to overcharge the … Continue reading Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
The DNA trap: DNA testing companies and the potential misuse of sensitive personal data
The ability of any firm to demonstrate that there are robust ethical frameworks within it, intertwined with essential governance and corporate social responsibility is critical. Over the last decade and a half, a new form of firms known as DNA testing and genealogical companies has arrived on the radar of those who want to understand … Continue reading The DNA trap: DNA testing companies and the potential misuse of sensitive personal data
Challenges and advantages of robotic nursing care: a social and ethical analysis
Robotics is an interdisciplinary branch of engineering and science that includes, inter alia, mechanical engineering, electrical engineering, and computer science. This emerging field of technological advancement deals with the connection of perception to action and where that connection is to be "intelligent," then artificial intelligence (AI) plays a fundamental role in robotics. Robotic technology has … Continue reading Challenges and advantages of robotic nursing care: a social and ethical analysis
The alarming rise in the costs of drugs and the irresponsible behavior of pharmaceutical companies
Among all existing industries, the pharmaceutical sector is differentiated by the unique feature that it aims to fight diseases and conditions, thus directly contributing to the improvement of lives across the globe. With a focus on a basic human need such as health, pharmaceuticals have proven to be a highly profitable, prosperous, and ever-growing industry. … Continue reading The alarming rise in the costs of drugs and the irresponsible behavior of pharmaceutical companies
Understaffing and its threats to patient safety: irresponsible behavior in pharmacy chains
Boots Pharmacy, part of the largest pharmacy chain in Europe and the United States, has once again found itself in the spotlight for yet another dispensing error. On the 14th of December, the incorrect medication was dispensed to a customer at a Basingstoke, Hampshire branch (United Kingdom). The pharmacist on duty filled the patient’s prescription for … Continue reading Understaffing and its threats to patient safety: irresponsible behavior in pharmacy chains
Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry
Thalidomide is a synthetic drug developed in 1954 by German pharmaceutical company, Chemie Grünenthal, for use as a sedative in the treatment of insomnia and anxiety. Because of its purported atoxic nature, the use of this “wonder drug” quickly became widespread all over Europe. It was initially used to treat conditions like colds, headaches, and … Continue reading Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry